Anupam Rasayan India Ltd Share Price & Stock Analysis

Anupam Rasayan India Ltd (NSE: ANURAS, BSE: 543275) is a Surat, Gujarat-based company in the Custom Synthesis and Specialty CDMO industry. With a market capitalisation of ₹13,389 Cr, it ranks #505 by market cap among the 6,137 Indian listed companies on FinBizNet, and #1 of 13 in Custom Synthesis and Specialty CDMO. At ₹1,101.60 (as of 25 Oct 2026), the share price is 22.1% below its 52-week high of ₹1,415.00 and 4.6% above its 52-week low of ₹1,053.60. The share price is down 2.2% over one year and down 11.8% over three months.

Key Metrics

Current Price₹1,101.60
Market Cap₹13,389 Cr
NSE SymbolANURAS
BSE Code543275
SectorMaterials > Chemicals > Speciality Chemicals
Sub-IndustrySpecialty Chemicals > Custom Synthesis and Specialty CDMO
P/E Ratio73.6
Return on Equity5.76%
Return on Assets3.66%
52-Week Range₹1,053.60 – ₹1,415.00
1-Year Price Change-2.2%
3-Month Price Change-11.8%
Beta (1Y)-0.28
Dividend Yield0.14%
HeadquartersSurat, Gujarat
Websitewww.anupamrasayan.com

Latest Quarterly Results — Q1 FY27

Revenue₹655 Cr
Net Profit₹51 Cr
Net Margin7.8%
EPS (Basic)₹3.39
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

About Anupam Rasayan India Ltd

Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients. It provides other specialty chemicals used in various end-user segments, including specialty pigments, specialty dyes, and polymer additives. The company was incorporated in 1984 and is headquartered in Surat, India.

Products and Services

1. Manufacturing of Industrial Chemicals-This segment engages in the custom synthesis business; and manufacturing of specialty chemicals.

Business Segments

1. Manufacturing of Industrial Chemicals-100%

Anupam Rasayan India Ltd vs Peers — Custom Synthesis and Specialty CDMO

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Anupam Rasayan India Ltd₹13,389 Cr73.65.76%₹655 Cr-2.2%
Neogen Chemicals Limited (Neogen)₹7,465 Cr227.63.58%₹250 Cr+45.2%
Laxmi Organic Industries Ltd₹4,963 Cr59.94.08%₹968 Cr-27.6%
Tatva Chintan Pharma Chem Ltd₹4,547 Cr105.85.53%₹217 Cr+22.0%
Prasol Chemicals Limited₹4,476 Cr50.7—₹434 Cr—
Paushak Ltd.₹2,046 Cr42.98.22%₹84 Cr—
Sunshield Chemicals Ltd.₹906 Cr27.717.02%—+12.6%
Chemcon Speciality Chemicals Limited₹803 Cr33.44.80%₹65 Cr-27.6%
Arvee Laboratories (India) Ltd₹249 Cr93.97.78%₹17 Cr+17.6%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Anupam Rasayan India Ltd?

Anupam Rasayan India Ltd is trading at ₹1,101.60, with a market capitalisation of ₹13,389 Cr.

Which sector does Anupam Rasayan India Ltd belong to?

Anupam Rasayan India Ltd operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Custom Synthesis and Specialty CDMO).

What are the key financial ratios of Anupam Rasayan India Ltd?

Anupam Rasayan India Ltd has a P/E of 73.6 and a return on equity of 5.76%.

What is the stock symbol of Anupam Rasayan India Ltd?

Anupam Rasayan India Ltd is listed on the NSE under the symbol ANURAS and on the BSE under the scrip code 543275.

How has Anupam Rasayan India Ltd's share price moved over the past year?

Anupam Rasayan India Ltd's share price is down 2.2% over one year and down 11.8% over three months. Its 52-week range is ₹1,053.60 to ₹1,415.00.

What were Anupam Rasayan India Ltd's latest quarterly results?

In Q1 FY27, Anupam Rasayan India Ltd reported revenue of ₹655 Cr and net profit of ₹51 Cr, with basic EPS of ₹3.39 (consolidated, parsed from the company's exchange filing).

More on FinBizNet

Data as of 25 Oct 2026. Descriptive market data only — not investment advice.